In a recent study, more KLF4 hotspot driver mutations were identified at high prevalence in low-grade intraductal papillary mucinous neoplasms (IPMNs) (Fujikura et al., 2020). This evidence concerns the gene KLF4 and pancreatic intraductal papillary-mucinous neoplasm.